Skip to main content
showDesktop,showTablet,showMobile

Causes, Risk Factors, and Prevention of Osteosarcoma

Osteosarcoma is a cancer that most commonly occurs in adolescents, teenagers, and young adults. While there are a few known genetic factors that increase the risk of osteosarcoma, the exact cause of most cases is not known.

What causes osteosarcoma?

Scientists have found some risk factors, but most children with osteosarcoma do not have any known risk factors. A risk factor is anything that affects a person’s chance of getting a disease, such as cancer.

How normal cells become osteosarcoma cells

DNA is the chemical in our cells that makes up our genes, which control how our cells function. Changes (mutations) in the DNA inside our cells can sometimes alter the way some genes work, which can cause cells to grow out of control and become cancer.

Some genes control when our cells grow, divide into new cells, and die:

  • Genes that help cells grow, divide, or stay alive can sometimes lose the ability to turn off and become oncogenes.
  • Genes that tell cells to stop dividing or cause cells to die at the right time are called tumor suppressor genes.
  • DNA repair genes find and fix damage to the DNA that might happen during cell growth or from the environment.

Acquired versus inherited gene changes in osteosarcoma

Cancers can be caused by DNA changes that create oncogenes, turn off tumor suppressor genes, or damage DNA repair genes. These gene changes can happen before birth randomly or be inherited from a parent (most germline events in osteosarcoma occur randomly and are not present in the parents). However, most gene changes that cause osteosarcoma happen by chance during a person’s lifetime. These acquired or de novo gene changes result from environmental exposures, like radiation, but most occur by chance.

Known risk factors for osteosarcoma typically fall into two categories: genetic or environmental. Researchers continue to search for answers about why bone cancers occur.

Genetic risk factors

Some children have gene changes in cells throughout the body. These can be inherited from a parent or randomly occur early in development (always before the child is born), increasing their risk of cancer. Some osteosarcomas are caused by these gene changes.

Genetic syndromes

Some genetic disorders increase a person’s risk of developing osteosarcoma:

Li-Fraumeni syndrome is a rare condition caused by a change in the TP53 gene. People with this change have a higher risk of developing several kinds of cancer, including leukemia, bone or soft tissue sarcomas, breast cancer, adrenal gland cancer, and brain tumors.

Inherited changes in the retinoblastoma (RB1) tumor suppressor gene increases the risk of developing retinoblastoma, a type of eye cancer in children. Children with this gene change also have an increased risk of developing osteosarcoma and melanoma, especially if they were treated with radiation.

This is a rare inherited change in the RECQL4 gene. It is associated with osteosarcoma and other problems with the skin, hair, and bones.

This genetic syndrome affects a protein called DNA helicase, which is important for cell growth and DNA repair. People with Werner syndrome tend to age earlier and have more cancers at young ages, most commonly sarcomas.

Bloom syndrome affects proteins important for cell growth and DNA repair. People with Bloom syndrome have trouble growing well, may have a weak immune system, and are more likely to develop cancers like leukemias and osteosarcoma.

This bone marrow failure syndrome causes low red blood cell counts. It increases the risk of developing certain cancers, like leukemia and osteosarcoma.

Research into other gene changes that may put some children or families at higher risk of having cancers like osteosarcoma is ongoing.

While specific inherited gene changes can cause some osteosarcomas, scientists have also found that conditions where the bones grow or remodel often can also increase the risk of osteosarcoma. These conditions include:

  • Paget disease of the bone: Causes quick turnover of the bones, leading to weak and enlarged bones.
  • McCune-Albright syndrome: Characterized by a triad of fibrous dysplasia of the bone, early puberty, and skin changes called café-au-lait spots.

Studies have even found that people of above-average height have a higher risk of developing osteosarcoma. This suggests that factors affecting growth and bone turnover may play a role in bone cancer risk.

If you are concerned that you or your child might possibly have an inherited gene change, talk with your doctor about whether genetic testing might be helpful. You can also read more in Genetics and Cancer.

Environmental risk factors

Most osteosarcomas are not caused by inherited gene mutations but instead result from gene changes acquired during a person’s lifetime.

Radiation exposure

People who were treated with radiation therapy for another cancer appear to have a higher risk of developing osteosarcoma in the treated area later. Being treated at a younger age and with higher doses of radiation both increase this risk.

It is not clear if imaging tests that use radiation, such as x-rays, CT scans, and nuclear medicine scans (e.g., PET scans or bone scans), raise the risk of developing osteosarcoma. The amount of radiation used for these tests is much lower than that used for radiation treatments. If there is any increased risk, it is likely very small. Still, doctors try to limit the use of these types of tests whenever possible, especially in children, just in case.

Can osteosarcoma be prevented?

Most known risk factors for osteosarcoma cannot be changed. While the risk for many adult cancers can be reduced with lifestyle changes, these factors do not play a major role in childhood cancers.

Other than exposure to radiation (usually during radiation therapy), there are no known lifestyle-related or environmental causes of osteosarcoma. There is no known way to protect against or prevent most of these cancers.

side by side logos for American Cancer Society and American Society of Clinical Oncology

Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).

Anderson ME, Dubois SG, Gebhart MC. Chapter 89: Sarcomas of bone. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa: Elsevier; 2020.

Gillani R, Collins RL, Crowdis J, Garza A, Jones JK, Walker M, Sanchis-Juan A, Whelan CW, Pierce-Hoffman E, Talkowski ME, Brand H, Haigis K, LoPiccolo J, AlDubayan SH, Gusev A, Crompton BD, Janeway KA, Van Allen EM. Rare germline structural variants increase risk for pediatric solid tumors. Science. 2025 Jan 3;387(6729):eadq0071. doi: 10.1126/science.adq0071.

Hansen MF, Seton M, Merchant A. Osteosarcoma in Paget’s disease of bone. J Bone Miner Res. 2006;21 Suppl 2:P58–63.

Janeway K, Randall R, Gorlick R. Chapter 28: Osteosarcoma. In: Blaney SM, Adamson PC, Helman LJ, eds. Pizzo and Poplack’s Pediatric Oncology . 8th ed. Philadelphia Pa: Lippincott Williams & Wilkins; 2021.

Mardekian SK, Tuluc M. Malignant sarcomatous transformation of fibrous dysplasia. Head Neck Pathol. 2015;9(1):100-103.

National Cancer Institute. Osteosarcoma and Undifferentiated Pleomorphic Sarcoma of Bone Treatment (PDQ). 2024. Accessed at https://www.cancer.gov/types/bone/hp/osteosarcoma-treatment-pdq on June 3, 2025.

National Comprehensive Cancer Network (NCCN). Practice Guidelines in Oncology: Bone Cancer. Version 2.2025. Accessed at www.nccn.org/professionals/physician_gls/pdf/bone.pdf on June 3, 2025.

Oak N, Chen W, Blake A, Harrison L, O'Brien M, Previti C, Balasubramanian G, Maass K, Hirsch S, Penkert J, Jones BC, Schramm K, Nathrath M, Pajtler KW, Jones DTW, Witt O, Dirksen U, Li J, Sapkota Y, Ness KK, Guenther LM, Pfister SM, Kratz C, Wang Z, Armstrong GT, Hudson MM, Wu G, Autry RJ, Nichols KE, Sharma R. Comprehensive investigation of DNA damage repair genes in children with cancer identifies SMARCAL1 as a novel osteosarcoma predisposition gene. medRxiv. 2025 Jun 4;2025.05.12.25325832. doi: 10.1101/2025.05.12.25325832.

Oshima J, Martin GM, Hisama FM. Werner Syndrome. 2002 Dec 2 [Updated 2021 May 13]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. Accessed at https://www.ncbi.nlm.nih.gov/books/NBK1514 on June 4, 2025.

Last Revised: August 21, 2025

American Cancer Society Emails

Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.